TG THERAPEUTICS, INC. Business Acquisition, Pro Forma Revenue
TG THERAPEUTICS, INC. (TGTX) reported Business Acquisition, Pro Forma Revenue of $0 for the 12-month period ending 2011-12-31, per its 10-K filed 2013-03-21.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2013-03-21
- TG THERAPEUTICS, INC. business acquisition, pro forma revenue for the quarter ending 2011-12-31 was $0.00.
- TG THERAPEUTICS, INC. business acquisition, pro forma revenue for the quarter ending 2011-09-30 was $0.00.
- TG THERAPEUTICS, INC. business acquisition, pro forma revenue for the quarter ending 2011-06-30 was $0.00.
- TG THERAPEUTICS, INC. business acquisition, pro forma revenue for fiscal 2011 was $0.00.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $0.00 derived: sum of 2 quarters · filed 2013-03-21 | $0.00 derived: sum of 3 quarters · filed 2013-03-21 | $0.00 10-K · filed 2013-03-21 |
| 2011-09-30 | $0.00 10-Q · filed 2012-11-14 | $0.00 derived: sum of 2 quarters · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-07 | $0.00 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |